CINNAMON AGAINST OBESITY – A SYSTEMATIC REVIEW
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.5772Keywords:
Cinnamon Supplementation; Obesity Management; Cinnamaldehyde; Polyphenols; Metabolic Syndrome; Insulin ResistanceAbstract
Introduction: Obesity is a major global health problem associated with metabolic disturbances, including insulin resistance, dyslipidemia, and chronic inflammation. Due to various limitations of pharmacological therapies, increasing attention has been directed toward natural compounds with potential metabolic benefits. This review aimed to evaluate the role of cinnamon and its bioactive constituents in obesity management.
Methodology: A comprehensive literature search was conducted using PubMed, Scopus, Web of Science, and Google Scholar. Studies investigating cinnamon and its bioactive compounds in relation to obesity, body weight, and metabolic parameters were included. Both experimental and clinical studies were analyzed according to predefined inclusion and exclusion criteria.
Results: Cinnamon contains bioactive compounds, particularly cinnamaldehyde and polyphenols, that influence key metabolic pathways. Experimental studies demonstrate inhibition of adipogenesis, stimulation of thermogenesis, and improvement of insulin sensitivity. Clinical studies suggest modest reductions in body weight and selected metabolic parameters, although results remain heterogeneous.
Conclusion: Cinnamon appears to be a promising supportive strategy in obesity and metabolic syndrome management; however, its clinical effectiveness remains limited. Further well-designed studies are required to determine optimal dosing, safety, and long-term efficacy.
References
Busebee, B., Ghusn, W., Cifuentes, L., & Acosta, A. (2023). Obesity: A review of pathophysiology and classification. Mayo Clinic Proceedings, 98(11), 1842–1857. https://doi.org/10.1016/j.mayocp.2023.05.026
Hruby, A., & Hu, F. B. (2015). The epidemiology of obesity: A big picture. Pharmacoeconomics, 33(7), 673–689. https://doi.org/10.1007/s40273-014-0243-x
Finkelstein, E. A., Khavjou, O. A., Thompson, H., et al. (2012). Obesity and severe obesity forecasts through 2030. American Journal of Preventive Medicine, 42(6), 563–570. https://doi.org/10.1016/j.amepre.2011.10.026
Rodríguez-Pérez, C., Segura-Carretero, A., & Del Mar Contreras, M. (2019). Phenolic compounds as natural and multifunctional anti-obesity agents: A review. Critical Reviews in Food Science and Nutrition, 59(8), 1212–1229. https://doi.org/10.1080/10408398.2017.1399859
Trayhurn, P., & Wood, I. S. (2004). Adipokines: Inflammation and the pleiotropic role of white adipose tissue. British Journal of Nutrition, 92(3), 347–355. https://doi.org/10.1079/BJN20041213
Monteiro, R., & Azevedo, I. (2010). Chronic inflammation in obesity and the metabolic syndrome. Mediators of Inflammation, 2010, Article 289645. https://doi.org/10.1155/2010/289645
Mollazadeh, H., & Hosseinzadeh, H. (2016). Cinnamon effects on metabolic syndrome: A review based on its mechanisms. Iranian Journal of Basic Medical Sciences, 19(12), 1258–1270. https://doi.org/10.22038/IJBMS.2016.7906
Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
Davies, M. J., Bergenstal, R., Bode, B., et al. (2015). Efficacy of liraglutide for weight loss among patients with type 2 diabetes: The SCALE diabetes randomized clinical trial. JAMA, 314(7), 687–699. https://doi.org/10.1001/jama.2015.9676
Jastreboff, A. M., Aronne, L. J., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity: Reply. New England Journal of Medicine, 387(15), 1434–1435. https://doi.org/10.1056/NEJMc2211120
Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs. placebo on weight loss maintenance in adults with overweight or obesity: The STEP 4 randomized clinical trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
Nauck, M. A., & Meier, J. J. (2019). Management of endocrine disease: Are all GLP-1 agonists equal in the treatment of type 2 diabetes? European Journal of Endocrinology, 181(6), R211–R234. https://doi.org/10.1530/EJE-19-0566
Smits, M. M., & Van Raalte, D. H. (2021). Safety of semaglutide. Frontiers in Endocrinology, 12, Article 645563. https://doi.org/10.3389/fendo.2021.645563
ElSayed, N. A., Aleppo, G., Aroda, V. R., et al. (2023). Classification and diagnosis of diabetes: Standards of care in diabetes—2023. Diabetes Care, 46(Suppl. 1), S19–S40. https://doi.org/10.2337/dc23-S002
Wang, S., Moustaid-Moussa, N., Chen, L., et al. (2014). Novel insights of dietary polyphenols and obesity. Journal of Nutritional Biochemistry, 25(1), 1–18. https://doi.org/10.1016/j.jnutbio.2013.09.001
Hsu, C. L., & Yen, G. C. (2007). Effects of flavonoids and phenolic acids on the inhibition of adipogenesis in 3T3-L1 adipocytes. Journal of Agricultural and Food Chemistry, 55(21), 8404–8410. https://doi.org/10.1021/jf071695r
Lu, M., Cao, Y., Xiao, J., Song, M., & Ho, C. T. (2018). Molecular mechanisms of the anti-obesity effect of bioactive ingredients in common spices: A review. Food & Function, 9(9), 4569–4581. https://doi.org/10.1039/C8FO01349G
Ranasinghe, P., Pigera, S., Premakumara, G. A. S., et al. (2013). Medicinal properties of “true” cinnamon (Cinnamomum zeylanicum): A systematic review. BMC Complementary and Alternative Medicine, 13, Article 275. https://doi.org/10.1186/1472-6882-13-275
Anderson, R. A., Broadhurst, C. L., Polansky, M. M., et al. (2004). Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. Journal of Agricultural and Food Chemistry, 52(1), 65–70. https://doi.org/10.1021/jf034916b
Rao, P. V., & Gan, S. H. (2014). Cinnamon: A multifaceted medicinal plant. Evidence-Based Complementary and Alternative Medicine, 2014, Article 642942. https://doi.org/10.1155/2014/642942
Weng, X., Ho, C. T., & Lu, M. (2024). Biological fate, functional properties, and design strategies for oral delivery systems for cinnamaldehyde. Food & Function, 15(12), 6217–6231. https://doi.org/10.1039/D4FO00614C
European Food Safety Authority. (2008). Coumarin in flavourings and other food ingredients with flavouring properties. EFSA Journal, 6(10), Article 793. https://doi.org/10.2903/j.efsa.2008.793
Newerli-Guz, J., & Smiechowska, M. (2022). Health benefits and risks of consuming spices on the example of black pepper and cinnamon. Foods, 11(18), Article 2746. https://doi.org/10.3390/foods11182746
Abraham, K., Wöhrlin, F., Lindtner, O., Heinemeyer, G., & Lampen, A. (2010). Toxicology and risk assessment of coumarin: Focus on human data. Molecular Nutrition & Food Research, 54(2), 228–239. https://doi.org/10.1002/mnfr.200900281
Page, M. J., McKenzie, J. E., Bossuyt, P. M., et al. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ, 372, Article n71. https://doi.org/10.1136/bmj.n71
Pages-Rebull, J., Pérez-Ràfols, C., Serrano, N., & Díaz-Cruz, J. (2024). Analytical methods for cinnamon authentication. Trends in Food Science & Technology, 146, Article 104388. https://doi.org/10.1016/j.tifs.2024.104388
Silva, M. L. T., Bernardo, M. A. S., Singh, J., & Mesquita, M. F. (2019). Beneficial uses of cinnamon in health and diseases: An interdisciplinary approach. In R. B. Singh, R. R. Watson, & T. Takahashi (Eds.), The role of functional food security in global health (pp. 565–576). Academic Press.
Weerasinghe, N., & Pushpitha, N. (2020). Cinnamon process technology. In K. V. Peter (Ed.), Handbook of herbs and spices (pp. 233–250). Springer.
Department of Cinnamon Development. (2022). Post-harvest technology. https://cinnamon.gov.lk/about-cinnamon/post-harvest-technology/
Bibi, T., et al. (2024). The therapeutic perspective of cinnamon (Cinnamomum verum) consumption against metabolic syndrome. Journal of Functional Foods, 122, Article 106545. https://doi.org/10.1016/j.jff.2024.106545
Singh, N., et al. (2021). Phytochemical and pharmacological review of Cinnamomum verum J. Presl—A versatile spice used in food and nutrition. Food Chemistry, 338, Article 127773. https://doi.org/10.1016/j.foodchem.2020.127773
Abeysekera, W., Arachchige, S. P. G., Ratnasooriya, W. D., & Medawatta, H. (2019). Antioxidant and glycemic regulatory properties potential of different maturity stages of leaf of Ceylon cinnamon (Cinnamomum zeylanicum Blume) in vitro. Evidence-Based Complementary and Alternative Medicine, 2019, Article 2693795. https://doi.org/10.1155/2019/2693795
Oh, J., et al. (2023). Effects of cinnamon (Cinnamomum zeylanicum) extract on adipocyte differentiation in 3T3-L1 cells and lipid accumulation in mice fed a high-fat diet. Nutrients, 15(24), Article 5110. https://doi.org/10.3390/nu15245110
Li, B., Li, J., & Hu, S. (2022). Cinnamon could improve hepatic steatosis caused by a high-fat diet via enhancing hepatic β-oxidation and inhibiting hepatic lipogenesis, oxidative damage, and inflammation in male rats. Journal of Food Biochemistry, 46(2), Article e14077. https://doi.org/10.1111/jfbc.14077
Kaur, N., et al. (2019). Cinnamon attenuates adiposity and affects the expression of metabolic genes in diet-induced obesity model of zebrafish. Artificial Cells, Nanomedicine, and Biotechnology, 47(1), 2930–2939. https://doi.org/10.1080/21691401.2019.1641509
Neto, J. G. O., et al. (2022). Cinnamaldehyde treatment during adolescence improves white and brown adipose tissue metabolism in a male rat model of early obesity. Food & Function, 13(6), 3405–3418. https://doi.org/10.1039/D1FO03871K
Kwan, H. Y., et al. (2017). Cinnamon induces browning in subcutaneous adipocytes. Scientific Reports, 7, Article 2447. https://doi.org/10.1038/s41598-017-02263-5
Tjandrawinata, R. R., Rosari, B. P., Syahputra, R. A., Surya, R., & Nurkolis, F. (2026). Cinnamon-derived phytonutrients as modulators of ion channels and G protein-coupled receptor signaling in metabolic diseases. Nutrients, 18(3), Article 547. https://doi.org/10.3390/nu18030547
Mousavi, S. M., et al. (2020). Cinnamon supplementation positively affects obesity: A systematic review and dose-response meta-analysis of randomized controlled trials. Clinical Nutrition, 39(1), 123–133. https://doi.org/10.1016/j.clnu.2019.02.017
Keramati, M., et al. (2022). Cinnamon, an effective anti-obesity agent: Evidence from an umbrella meta-analysis. Journal of Food Biochemistry, 46(6), Article e14166. https://doi.org/10.1111/jfbc.14166
Fadheel, Q. J. (2024). Assessment of the potential effects of L-carnitine and cinnamon supplementation on weight loss and body composition. Wiadomości Lekarskie, 77(3), 472–483. https://doi.org/10.36740/WLek202403115
Sabzevari Rad, R., Omidi, H., & Alipour, M. (2025). The combined effects of Tabata training and cinnamon supplementation on metabolic changes and body composition in soldiers with overweight or obesity. Journal of the International Society of Sports Nutrition, 22(1), Article 2564237. https://doi.org/10.1080/15502783.2025.2564237
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Mikołaj Zbrożek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń, Anna Skrzypek, Maciej Hutkowski, Zuzanna Chwostek, Bartłomiej Kosiarski, Patrycja Markowicz, Krzysztof Biłyk

This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.

